A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews.
Su GolderKaren SmithKaren O'ConnorRobert GrossSean HennessyGraciela Gonzalez-HernandezPublished in: Drug safety (2020)
Combining the data from multiple sources, albeit challenging, may provide a broader safety profile of any medication. Systematically collected social media reports may be able to contribute information on the most pertinent adverse effects to patients.
Keyphrases
- social media
- health information
- end stage renal disease
- big data
- electronic health record
- adverse drug
- ejection fraction
- systematic review
- chronic kidney disease
- newly diagnosed
- cardiovascular disease
- healthcare
- prognostic factors
- transcription factor
- peritoneal dialysis
- drinking water
- randomized controlled trial
- artificial intelligence